Real-world study assesses first-line anti-PD-1, IFN-α1b, and anlotinib for advanced melanoma
A real-world study of patients with unresectable advanced melanoma in China has found that adding the cancer drug anlotinib to ...
A real-world study of patients with unresectable advanced melanoma in China has found that adding the cancer drug anlotinib to ...
A recent breakthrough in the treatment of HER2-positive alpha-fetoprotein-producing gastric cancer (AFPGC) offers a new beacon of hope for patients ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine